Jin Cai Li
Directeur Général chez WUXI XDC CAYMAN INC.
Profil
Jin Cai Li is currently the Chief Executive Officer & Executive Director at WuXi XDC Cayman, Inc. Prior to this, Dr. Li worked as a Staff Scientist at Diversa Corp.
and as a Scientist at Tanox, Inc. Dr. Li received an undergraduate degree from Tsinghua University in 1996 and a doctorate degree from the University of Maryland Medical Center in 2001.
Postes actifs de Jin Cai Li
| Sociétés | Poste | Début |
|---|---|---|
| WUXI XDC CAYMAN INC. | Directeur Général | 01/12/2020 |
Anciens postes connus de Jin Cai Li
| Sociétés | Poste | Fin |
|---|---|---|
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | 28/10/2013 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - |
Formation de Jin Cai Li
| Tsinghua University | Undergraduate Degree |
| University of Maryland Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WUXI XDC CAYMAN INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |